Skip to main content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Neuropraxis 6/2002

01-12-2002 | Artikelen

Risicofactoren voor dementie en achteruitgang in cognitieve functies

Auteurs: Mirjam Geerlings, Sandra Kalmijn

Gepubliceerd in: Neuropraxis | Uitgave 6/2002

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Dementie is een klinisch syndroom met een progressief ziektebeloop. Om tot de diagnose dementie te komen moeten er, per definitie, ernstige geheugenstoornissen aanwezig zijn en stoornissen in andere cognitieve functies, zoals afasie, apraxie, agnosie, of stoornissen in de uitvoerende functies. De cognitieve stoornissen moeten zodanig zijn dat zij duidelijk het sociaal of beroepsmatig functioneren beperken, vooral ten opzichte van het vroegere functioneren. Doordat veel ouderen enige mate van achteruitgang in het geheugen en andere cognitieve functies hebben, is het onderscheid tussen normale en pathologische cognitieve achteruitgang moeilijk te maken. In deze bijdrage zullen wij ons vooral richten op risicofactoren voor dementie, en in sommige gevallen ook op cognitieve achteruitgang, met de assumptie dat dit een voorstadium van dementie betreft.
Literatuur
go back to reference Aronson M.K., W.L. Ooi, H. Morgenstern, A. Hafner, D. Masur, H. Crystal et al. (1990).Women, myocardial infarction, and dementia in the very old. Neurology 40:1102-1106. Aronson M.K., W.L. Ooi, H. Morgenstern, A. Hafner, D. Masur, H. Crystal et al. (1990).Women, myocardial infarction, and dementia in the very old. Neurology 40:1102-1106.
go back to reference Bassuk S.S., L.F. Berkman & D. Wypij (1998). Depressive symptomatology and incident cognitive decline in an elderly community sample. Arch Gen Psychiatry 55:1073-1081. Bassuk S.S., L.F. Berkman & D. Wypij (1998). Depressive symptomatology and incident cognitive decline in an elderly community sample. Arch Gen Psychiatry 55:1073-1081.
go back to reference Breteler M.M. (2000). Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging 21:153-160. Breteler M.M. (2000). Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging 21:153-160.
go back to reference Chen P., M. Ganguli, B.H. Mulsant & S.T. DeKosky (1999). The temporal relationship between depressive symptoms and dementia: a community-based prospective study. Arch Gen Psychiatry 56:261-266. Chen P., M. Ganguli, B.H. Mulsant & S.T. DeKosky (1999). The temporal relationship between depressive symptoms and dementia: a community-based prospective study. Arch Gen Psychiatry 56:261-266.
go back to reference Christen Y. (2000). Oxidative stress and Alzheimer disease. Am J Clin Nutr 71:621S-629S. Christen Y. (2000). Oxidative stress and Alzheimer disease. Am J Clin Nutr 71:621S-629S.
go back to reference Cruts M. & C. van Broeckhoven (1998). Molecular genetics of Alzheimer's disease. Ann Med 30:560-565. Cruts M. & C. van Broeckhoven (1998). Molecular genetics of Alzheimer's disease. Ann Med 30:560-565.
go back to reference Das U.N. (2002). Estrogen, statins, and polyunsaturated fatty acids: similarities in their actions and benefits-is there a common link? Nutrition 18:178-188. Das U.N. (2002). Estrogen, statins, and polyunsaturated fatty acids: similarities in their actions and benefits-is there a common link? Nutrition 18:178-188.
go back to reference Devanand D.P., M. Sano, M.X. Tang, S. Taylor, B.J. Gurland, D. Wilder et al. (1996). Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry 53:175-182. Devanand D.P., M. Sano, M.X. Tang, S. Taylor, B.J. Gurland, D. Wilder et al. (1996). Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry 53:175-182.
go back to reference Engelhart M.J., M.I. Geerlings, A. Ruitenberg, J.C. van Swieten, A. Hofman, J.C. Witteman et al. (2002). Dietary intake of antioxidants and risk of Alzheimer disease. jama 287:3223-3229. Engelhart M.J., M.I. Geerlings, A. Ruitenberg, J.C. van Swieten, A. Hofman, J.C. Witteman et al. (2002). Dietary intake of antioxidants and risk of Alzheimer disease. jama 287:3223-3229.
go back to reference Fabrigoule C., L. Letenneur, J.F. Dartigues, M. Zarrouk, D. Commenges & P. Barberger-Gateau (1995). Social and leisure activities and risk of dementia: a prospective longitudinal study. J Am Geriatr Soc 43:485-490. Fabrigoule C., L. Letenneur, J.F. Dartigues, M. Zarrouk, D. Commenges & P. Barberger-Gateau (1995). Social and leisure activities and risk of dementia: a prospective longitudinal study. J Am Geriatr Soc 43:485-490.
go back to reference Geerlings M.I., B. Schmand, C. Jonker, J. Lindeboom, L.M. Bouter (1999). Education and incident Alzheimer's disease: a biased association due to selective attrition and use of a two-step diagnostic procedure? Int J Epidemiol 28:492-497. Geerlings M.I., B. Schmand, C. Jonker, J. Lindeboom, L.M. Bouter (1999). Education and incident Alzheimer's disease: a biased association due to selective attrition and use of a two-step diagnostic procedure? Int J Epidemiol 28:492-497.
go back to reference Geerlings M.I., R.A. Schoevers, A.T. Beekman, C. Jonker, D.J. Deeg, B. Schmand et al. (2000). Depression and risk of cognitive decline and Alzheimer's disease. Results of two prospective community-based studies in The Netherlands. Br J Psychiatry 176:568-575. Geerlings M.I., R.A. Schoevers, A.T. Beekman, C. Jonker, D.J. Deeg, B. Schmand et al. (2000). Depression and risk of cognitive decline and Alzheimer's disease. Results of two prospective community-based studies in The Netherlands. Br J Psychiatry 176:568-575.
go back to reference Geerlings M.I., A. Ruitenberg, J.C. Witteman, J.C. van Swieten, A. Hofman, C.M. van Duijn et al. (2001). Reproductive period and risk of dementia in postmenopausal women. jama 285:1475-1481. Geerlings M.I., A. Ruitenberg, J.C. Witteman, J.C. van Swieten, A. Hofman, C.M. van Duijn et al. (2001). Reproductive period and risk of dementia in postmenopausal women. jama 285:1475-1481.
go back to reference Haan M.N., L. Shemanski, W.J. Jagust, T.A. Manolio & L. Kuller (1999). The role of apoe epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. jama282:40-46. Haan M.N., L. Shemanski, W.J. Jagust, T.A. Manolio & L. Kuller (1999). The role of apoe epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. jama282:40-46.
go back to reference Henderson V.W., A. Paganini-Hill, B.L. Miller, R.J. Elble, P.F. Reyes, D. Shoupe et al. (2000). Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology 54:295-301. Henderson V.W., A. Paganini-Hill, B.L. Miller, R.J. Elble, P.F. Reyes, D. Shoupe et al. (2000). Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology 54:295-301.
go back to reference Hofman A., A. Ott, M.M. Breteler, M.L. Bots, A.J. Slooter, F. van Harskamp et al. (1997). Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 349:151-154. Hofman A., A. Ott, M.M. Breteler, M.L. Bots, A.J. Slooter, F. van Harskamp et al. (1997). Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 349:151-154.
go back to reference In ’t Veld B.A., A. Ruitenberg, A. Hofman, L.J. Launer, C.M. van Duijn, T. Stijnen et al. (2001). Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 345:1515-1521. In ’t Veld B.A., A. Ruitenberg, A. Hofman, L.J. Launer, C.M. van Duijn, T. Stijnen et al. (2001). Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 345:1515-1521.
go back to reference Kalmijn S., E.J. Feskens, L.J. Launer & D. Kromhout (1996). Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men. Stroke 1996; 27:2230-2235. Kalmijn S., E.J. Feskens, L.J. Launer & D. Kromhout (1996). Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men. Stroke 1996; 27:2230-2235.
go back to reference Kalmijn S., L.J. Launer, A. Ott, J.C. Witteman, A. Hofman & M.M. Breteler (1997a). Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 42:776-782. Kalmijn S., L.J. Launer, A. Ott, J.C. Witteman, A. Hofman & M.M. Breteler (1997a). Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 42:776-782.
go back to reference Kalmijn S., E.J. Feskens, L.J. Launer & D. Kromhout (1997b). Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol 145:33-41. Kalmijn S., E.J. Feskens, L.J. Launer & D. Kromhout (1997b). Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol 145:33-41.
go back to reference Kalmijn S., L.J. Launer, J. Lindemans, M.L. Bots, A. Hofman & M.M. Breteler (1999). Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am J Epidemiol 150:283-289. Kalmijn S., L.J. Launer, J. Lindemans, M.L. Bots, A. Hofman & M.M. Breteler (1999). Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am J Epidemiol 150:283-289.
go back to reference Kalmijn S., K.M. Mehta, H.A. Pols, A. Hofman, H.A. Drexhage & M.M. Breteler (2000). Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol (Oxf) 53:733-737. Kalmijn S., K.M. Mehta, H.A. Pols, A. Hofman, H.A. Drexhage & M.M. Breteler (2000). Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol (Oxf) 53:733-737.
go back to reference Kukull W.A. (2001). The association between smoking and Alzheimer's disease: effects of study design and bias. Biol Psychiatry 49:194-199. Kukull W.A. (2001). The association between smoking and Alzheimer's disease: effects of study design and bias. Biol Psychiatry 49:194-199.
go back to reference Launer L.J., K. Andersen, M.E. Dewey, L. Letenneur, A. Ott, L.A. Amaducci et al. (1999). Rates and risk factors for dementia and Alzheimer's disease: results from eurodem pooled analyses. eurodem Incidence Research Group and Work Groups. European Studies of Dementia. Neurology 52:78-84. Launer L.J., K. Andersen, M.E. Dewey, L. Letenneur, A. Ott, L.A. Amaducci et al. (1999). Rates and risk factors for dementia and Alzheimer's disease: results from eurodem pooled analyses. eurodem Incidence Research Group and Work Groups. European Studies of Dementia. Neurology 52:78-84.
go back to reference Launer L.J. (2000). Is there epidemiologic evidence that anti-oxidants protect against disorders in cognitive function? J Nutr Health Aging 4:197-201. Launer L.J. (2000). Is there epidemiologic evidence that anti-oxidants protect against disorders in cognitive function? J Nutr Health Aging 4:197-201.
go back to reference Launer L.J., G.W. Ross, H. Petrovitch, K. Masaki, D. Foley, L.R. White et al. (2000). Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging 21:49-55. Launer L.J., G.W. Ross, H. Petrovitch, K. Masaki, D. Foley, L.R. White et al. (2000). Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging 21:49-55.
go back to reference Laurin D., R. Verreault, J. Lindsay, K. MacPherson & K. Rockwood (2001). Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol 58:498-504. Laurin D., R. Verreault, J. Lindsay, K. MacPherson & K. Rockwood (2001). Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol 58:498-504.
go back to reference Letenneur L., L.J. Launer, K. Andersen, M.E. Dewey, A. Ott, J.R. Copeland et al. (2000). Education and the risk for Alzheimer's disease: sex makes a difference. eurodem pooled analyses. eurodem Incidence Research Group. Am J Epidemiol 151:1064-1071. Letenneur L., L.J. Launer, K. Andersen, M.E. Dewey, A. Ott, J.R. Copeland et al. (2000). Education and the risk for Alzheimer's disease: sex makes a difference. eurodem pooled analyses. eurodem Incidence Research Group. Am J Epidemiol 151:1064-1071.
go back to reference Lobo A., L.J. Launer, L. Fratiglioni, K. Andersen, A. Di Carlo, M.M. Breteler et al. (2000). Prevalence of dementia and major subtypes in Europe:A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54:S4-S9. Lobo A., L.J. Launer, L. Fratiglioni, K. Andersen, A. Di Carlo, M.M. Breteler et al. (2000). Prevalence of dementia and major subtypes in Europe:A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54:S4-S9.
go back to reference Merchant C., M.X. Tang, S. Albert, J. Manly, Y. Stern & R. Mayeux (1999). The influence of smoking on the risk of Alzheimer's disease. Neurology 52:1408-1412. Merchant C., M.X. Tang, S. Albert, J. Manly, Y. Stern & R. Mayeux (1999). The influence of smoking on the risk of Alzheimer's disease. Neurology 52:1408-1412.
go back to reference Morris M.C., D.A. Evans, J.L. Bienias, C.C. Tangney, D.A. Bennett, N. Aggarwal et al. (2002). Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. jama 287:3230-3237. Morris M.C., D.A. Evans, J.L. Bienias, C.C. Tangney, D.A. Bennett, N. Aggarwal et al. (2002). Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. jama 287:3230-3237.
go back to reference Muldoon M.F., S.D. Barger, C.M. Ryan, J.D. Flory, J.P. Lehoczky, K.A. Matthews et al. (2000). Effects of lovastatin on cognitive function and psychological well-being. Am J Med 2000; 108(7):538-546. Muldoon M.F., S.D. Barger, C.M. Ryan, J.D. Flory, J.P. Lehoczky, K.A. Matthews et al. (2000). Effects of lovastatin on cognitive function and psychological well-being. Am J Med 2000; 108(7):538-546.
go back to reference Mulnard R.A., C.W. Cotman, C. Kawas, C.H. van Dyck, M. Sano, R. Doody et al. (2000). Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. jama 283:1007-1015. Mulnard R.A., C.W. Cotman, C. Kawas, C.H. van Dyck, M. Sano, R. Doody et al. (2000). Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. jama 283:1007-1015.
go back to reference Ott A., R.P. Stolk, A. Hofman, F. van Harskamp, D.E. Grobbee & M.M. Breteler (1996). Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 39:1392-1397. Ott A., R.P. Stolk, A. Hofman, F. van Harskamp, D.E. Grobbee & M.M. Breteler (1996). Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 39:1392-1397.
go back to reference Ott A., A.J. Slooter, A. Hofman, F. van Harskamp, J.C. Witteman, C. van Broeckhoven et al. (1998). Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet 351:1840-1843. Ott A., A.J. Slooter, A. Hofman, F. van Harskamp, J.C. Witteman, C. van Broeckhoven et al. (1998). Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet 351:1840-1843.
go back to reference Peila R., B.L. Rodriguez & L.J. Launer. (2002). Type 2 diabetes, apoe gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 51:1256-1262. Peila R., B.L. Rodriguez & L.J. Launer. (2002). Type 2 diabetes, apoe gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 51:1256-1262.
go back to reference Ruitenberg A., A. Ott, J.C. van Swieten, A. Hofman & M.M. Breteler (2001). Incidence of dementia: does gender make a difference? Neurobiol Aging 22:575-580. Ruitenberg A., A. Ott, J.C. van Swieten, A. Hofman & M.M. Breteler (2001). Incidence of dementia: does gender make a difference? Neurobiol Aging 22:575-580.
go back to reference Ruitenberg A., I. Skoog, A. Ott, O. Aevarsson, J.C. Witteman, B. Lernfelt et al. (2001). Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study. Dement Geriatr Cogn Disord 12:33-39. Ruitenberg A., I. Skoog, A. Ott, O. Aevarsson, J.C. Witteman, B. Lernfelt et al. (2001). Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study. Dement Geriatr Cogn Disord 12:33-39.
go back to reference Ruitenberg A., J.C. van Swieten, J.C. Witteman, K.M. Mehta, C.M. van Duijn, A. Hofman et al. (2002). Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet 359:281-286. Ruitenberg A., J.C. van Swieten, J.C. Witteman, K.M. Mehta, C.M. van Duijn, A. Hofman et al. (2002). Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet 359:281-286.
go back to reference Sano M., C. Ernesto, R.G. Thomas, M.R. Klauber, K. Schafer, M. Grundman et al. (1997). A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 336:1216-1222. Sano M., C. Ernesto, R.G. Thomas, M.R. Klauber, K. Schafer, M. Grundman et al. (1997). A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 336:1216-1222.
go back to reference Sapolsky R.M., L.C. Krey & B.S. McEwen (1986). The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev 7:284-301. Sapolsky R.M., L.C. Krey & B.S. McEwen (1986). The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev 7:284-301.
go back to reference Sapolsky R.M. (2000). Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57:925-35. Sapolsky R.M. (2000). Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57:925-35.
go back to reference Scarmeas N., G. Levy, M.X. Tang, J. Manly & Y. Stern (2001). Influence of leisure activity on the incidence of Alzheimer's disease. Neurology 57:2236-2242. Scarmeas N., G. Levy, M.X. Tang, J. Manly & Y. Stern (2001). Influence of leisure activity on the incidence of Alzheimer's disease. Neurology 57:2236-2242.
go back to reference Scott H.D. & K. Laake K. (2001). Statins for the reduction of risk of Alzheimer's disease. Cochrane Database Syst Rev (3):CD003160. Scott H.D. & K. Laake K. (2001). Statins for the reduction of risk of Alzheimer's disease. Cochrane Database Syst Rev (3):CD003160.
go back to reference Seshadri S., A. Beiser, J. Selhub, P.F. Jacques, I.H. Rosenberg, R.B. d'Agostino et al. (2002).Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346:476-483. Seshadri S., A. Beiser, J. Selhub, P.F. Jacques, I.H. Rosenberg, R.B. d'Agostino et al. (2002).Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346:476-483.
go back to reference Skoog I., B. Lernfelt, S. Landahl, B. Palmertz, L.A. Andreasson, L. Nilsson (1996). et al. 15-year longitudinal study of blood pressure and dementia. Lancet 347:1141-1145. Skoog I., B. Lernfelt, S. Landahl, B. Palmertz, L.A. Andreasson, L. Nilsson (1996). et al. 15-year longitudinal study of blood pressure and dementia. Lancet 347:1141-1145.
go back to reference Snowdon D.A., L.H. Greiner, J.A. Mortimer, K.P. Riley, P.A. Greiner & W.R. Markesbery (1997). Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. jama 277:813-817. Snowdon D.A., L.H. Greiner, J.A. Mortimer, K.P. Riley, P.A. Greiner & W.R. Markesbery (1997). Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. jama 277:813-817.
go back to reference Schmidt R., H. Schmidt, J.D. Curb, K. Masaki, L.R. White & L.J. Launer (2002). Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 52:168-74. Schmidt R., H. Schmidt, J.D. Curb, K. Masaki, L.R. White & L.J. Launer (2002). Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 52:168-74.
go back to reference Sorbi S., P. Forleo, A. Tedde, E. Cellini, M. Ciantelli, S. Bagnoli et al. (2001). Genetic risk factors in familial Alzheimer's disease. Mech Ageing Dev 122:1951-1960. Sorbi S., P. Forleo, A. Tedde, E. Cellini, M. Ciantelli, S. Bagnoli et al. (2001). Genetic risk factors in familial Alzheimer's disease. Mech Ageing Dev 122:1951-1960.
go back to reference Stern Y., B. Gurland, T.K. Tatemichi, M.X. Tang, D. Wilder & R. Mayeux (1994). Influence of education and occupation on the incidence of Alzheimer's disease. jama 271:1004-1010. Stern Y., B. Gurland, T.K. Tatemichi, M.X. Tang, D. Wilder & R. Mayeux (1994). Influence of education and occupation on the incidence of Alzheimer's disease. jama 271:1004-1010.
go back to reference Stern Y. (2002). What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 8:448-460. Stern Y. (2002). What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 8:448-460.
go back to reference Tang M.X., D. Jacobs, Y. Stern, K. Marder, P. Schofield, B. Gurland et al. (1996). Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348:429-432. Tang M.X., D. Jacobs, Y. Stern, K. Marder, P. Schofield, B. Gurland et al. (1996). Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348:429-432.
go back to reference Volpato S., J.M. Guralnik, L.P. Fried, A.T. Remaley, A.R. Cappola & L.J. Launer (2002). Serum thyroxine level and cognitive decline in euthyroid older women. Neurology 58:1055-1061. Volpato S., J.M. Guralnik, L.P. Fried, A.T. Remaley, A.R. Cappola & L.J. Launer (2002). Serum thyroxine level and cognitive decline in euthyroid older women. Neurology 58:1055-1061.
go back to reference Wang H.X., A. Karp, B. Winblad & L. Fratiglioni (2002). Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: a longitudinal study from the kungsholmen project. Am J Epidemiol 155:1081-1087. Wang H.X., A. Karp, B. Winblad & L. Fratiglioni (2002). Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: a longitudinal study from the kungsholmen project. Am J Epidemiol 155:1081-1087.
go back to reference Wolozin B., W. Kellman, P. Ruosseau, G.G. Celesia & G. Siegel (2000). Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 57:1439-1443. Wolozin B., W. Kellman, P. Ruosseau, G.G. Celesia & G. Siegel (2000). Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 57:1439-1443.
go back to reference Yaffe K., D. Barnes, M. Nevitt, L.Y. Lui & K. Covinsky (2002). A prospective study of physical activity and cognitive decline in elderly women: women who walk. Arch Intern Med 161:1703-1708. Yaffe K., D. Barnes, M. Nevitt, L.Y. Lui & K. Covinsky (2002). A prospective study of physical activity and cognitive decline in elderly women: women who walk. Arch Intern Med 161:1703-1708.
go back to reference Yaffe K., T. Blackwell, R. Gore, L. Sands, V. Reus & W.S. Browner (1999). Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study. Arch Gen Psychiatry 56:425-430. Yaffe K., T. Blackwell, R. Gore, L. Sands, V. Reus & W.S. Browner (1999). Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study. Arch Gen Psychiatry 56:425-430.
go back to reference Yaffe K., G. Sawaya, I. Lieberburg & D. Grady (1998). Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. jama 279:688-695. Yaffe K., G. Sawaya, I. Lieberburg & D. Grady (1998). Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. jama 279:688-695.
go back to reference Yoshitake T., Y. Kiyohara, I. Kato, T. Ohmura, H. Iwamoto, K. Nakayama et al. (1995). Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 45:1161-1168. Yoshitake T., Y. Kiyohara, I. Kato, T. Ohmura, H. Iwamoto, K. Nakayama et al. (1995). Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 45:1161-1168.
Metagegevens
Titel
Risicofactoren voor dementie en achteruitgang in cognitieve functies
Auteurs
Mirjam Geerlings
Sandra Kalmijn
Publicatiedatum
01-12-2002
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Neuropraxis / Uitgave 6/2002
Print ISSN: 1387-5817
Elektronisch ISSN: 1876-5785
DOI
https://doi.org/10.1007/BF03071034

Andere artikelen Uitgave 6/2002

Neuropraxis 6/2002 Naar de uitgave